Treatment Information

Back

Colon Cancer treatment details. Biologic therapy.

Kantonsspital St Gallen , St Gallen , Switzerland.

Survival: monthsCountry:Switzerland
Toxiciy Grade:4City/State/Province:St Gallen
Treatments:Biologic therapyHospital:Kantonsspital St Gallen
Drugs:Journal:Link
Date:Jan 2015

Description:

Patients:
This phase 3 study involved 131 previously treated metastatic colorectal cancer patients. The median patient age was 63 years and 71% were male.

Treatment:
Patients received biologic therapy with bevacizumab.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 high blood pressure and thrombosis (blood clotting).

Results:
The median overall survival was 25.4 months.

Support:
Some of the study’s authors have received financial support from various pharmaceutical companies.

Correspondence: Dr. Dieter Koeberle; email: [email protected]



Back